CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week Left Ventricular Assist Devices: Synergistic Model Between Technology and Medicine Vaccination Trends in Patients With Heart Failure - Insights From Get With The Guidelines–Heart Failure Antithrombotics From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5) Heart Failure With Preserved Ejection Fraction in the Young Ejection Fraction Pros and Cons: JACC State-of-the-Art Review A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report

Clinical TrialVolume 73, Issue 1, January 2019

JOURNAL:J Am Coll Cardiol. Article Link

Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women

P Dewan, R Rørth, JJV McMurray et al. Keywords: HFrEF; gender; comorbidity; mortality; quality of life

FULL TEXT PDF